| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.89% | -1.14% | -14.12% | -9.79% | -8.06% | 78 219 |
| VERTEX PHARMACEUTICALS | 1.96% | -1.79% | 30.84% | 42.09% | 58.01% | 73 484 |
| REGENERON PHARMACEUTICALS, INC. | 0.72% | -2.79% | -5.72% | 3.62% | 88.08% | 64 152 |
 | WUXI APPTEC CO., LTD. | -1.14% | -0.64% | -13.31% | -38.81% | 165.41% | 44 566 |
| BIONTECH SE | 5.63% | 17.50% | -38.91% | -29.69% | --.--% | 38 276 |
 | GENMAB A/S | 2.79% | 5.78% | -10.23% | -8.56% | 95.29% | 21 607 |
| BEIGENE, LTD. | 3.15% | -6.20% | -38.38% | -52.25% | 31.42% | 17 253 |
| NEUROCRINE BIOSCIENCES, INC. | 1.82% | 1.03% | 16.53% | 1.84% | 16.49% | 9 486 |
| LEGEND BIOTECH CORPORATION | 1.53% | 5.64% | 19.80% | 33.65% | --.--% | 8 612 |
| EXELIXIS, INC. | 3.60% | -2.93% | 18.00% | 15.72% | 0.33% | 6 918 |
| SAREPTA THERAPEUTICS, INC. | 1.00% | 0.65% | -15.92% | -3.27% | -51.65% | 6 625 |
| HALOZYME THERAPEUTICS, INC. | 1.09% | -5.98% | 10.62% | -4.06% | 153.16% | 6 128 |
| INTRA-CELLULAR THERAPIES, INC. | -3.35% | -0.81% | 5.41% | 29.84% | 293.23% | 5 204 |
| ASCENDIS PHARMA A/S | -0.39% | 1.66% | -31.17% | -31.15% | -22.12% | 5 168 |
 | PHARMAESSENTIA CORPORATION | -4.13% | 0.30% | 70.14% | 472.33% | 317.15% | 4 751 |
| | | | | | | |
| | Gemiddelde | 1.01% | 0.69% | 0.24% | 28.10% | 87.44% | |
| | Gewogen gemiddelde per kap. | 1.46% | 0.69% | -3.99% | 3.11% | 66.74% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
